LivaNova PE Ratio 2012-2025 | LIVN
Current and historical p/e ratio for LivaNova (LIVN) from 2012 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. LivaNova PE ratio as of November 07, 2025 is 14.62.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| LivaNova PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-11-07 | 50.45 | 0.00 | |
| 2025-09-30 | 52.38 | $-4.49 | 0.00 |
| 2025-06-30 | 45.02 | $-3.89 | 0.00 |
| 2025-03-31 | 39.28 | $-4.09 | 0.00 |
| 2024-12-31 | 46.31 | $1.14 | 40.62 |
| 2024-09-30 | 52.54 | $0.42 | 125.10 |
| 2024-06-30 | 54.82 | $-0.32 | 0.00 |
| 2024-03-31 | 55.94 | $-0.60 | 0.00 |
| 2023-12-31 | 51.74 | $0.32 | 161.69 |
| 2023-09-30 | 52.88 | $0.05 | 1057.60 |
| 2023-06-30 | 51.43 | $-1.82 | 0.00 |
| 2023-03-31 | 43.58 | $-1.54 | 0.00 |
| 2022-12-31 | 55.54 | $-1.62 | 0.00 |
| 2022-09-30 | 50.77 | $-1.75 | 0.00 |
| 2022-06-30 | 62.47 | $-0.56 | 0.00 |
| 2022-03-31 | 81.83 | $-1.99 | 0.00 |
| 2021-12-31 | 87.43 | $-2.66 | 0.00 |
| 2021-09-30 | 79.19 | $-8.31 | 0.00 |
| 2021-06-30 | 84.11 | $-7.79 | 0.00 |
| 2021-03-31 | 73.73 | $-8.47 | 0.00 |
| 2020-12-31 | 66.21 | $-7.09 | 0.00 |
| 2020-09-30 | 45.21 | $-4.30 | 0.00 |
| 2020-06-30 | 48.13 | $-3.34 | 0.00 |
| 2020-03-31 | 45.25 | $-2.13 | 0.00 |
| 2019-12-31 | 75.43 | $-3.21 | 0.00 |
| 2019-09-30 | 73.79 | $-4.59 | 0.00 |
| 2019-06-30 | 71.96 | $-5.40 | 0.00 |
| 2019-03-31 | 97.25 | $-4.49 | 0.00 |
| 2018-12-31 | 91.47 | $-3.91 | 0.00 |
| 2018-09-30 | 123.97 | $-1.89 | 0.00 |
| 2018-06-30 | 99.82 | $-1.17 | 0.00 |
| 2018-03-31 | 88.50 | $-0.50 | 0.00 |
| 2017-12-31 | 79.92 | $-0.54 | 0.00 |
| 2017-09-30 | 70.06 | $1.17 | 59.88 |
| 2017-06-30 | 61.21 | $0.57 | 107.39 |
| 2017-03-31 | 49.01 | $-0.23 | 0.00 |
| 2016-12-31 | 44.97 | $-1.29 | 0.00 |
| 2016-09-30 | 60.11 | $-0.68 | 0.00 |
| 2016-06-30 | 50.23 | $-0.65 | 0.00 |
| 2016-03-31 | 53.98 | $-0.83 | 0.00 |
| 2015-12-31 | 59.37 | 0 | 0.00 |
| 2015-10-31 | 66.28 | $0.47 | 141.02 |
| 2015-09-30 | 60.78 | $0.47 | 129.32 |
| 2015-07-31 | 61.40 | $0.87 | 70.57 |
| 2015-06-30 | 59.46 | $0.87 | 68.34 |
| 2015-04-30 | 60.91 | $0.40 | 152.28 |
| 2015-03-31 | 64.92 | $0.40 | 162.30 |
| 2015-01-31 | 55.57 | 0 | 0.00 |
| 2014-10-31 | 52.50 | 0 | 0.00 |
| 2014-07-31 | 59.47 | 0 | 0.00 |
| 2014-04-30 | 59.16 | 0 | 0.00 |
| 2014-01-31 | 66.80 | 0 | 0.00 |
| 2013-10-31 | 57.76 | 0 | 0.00 |
| 2013-07-31 | 51.99 | 0 | 0.00 |
| 2013-04-30 | 43.42 | 0 | 0.00 |
| 2013-01-31 | 43.36 | 0 | 0.00 |
| 2012-10-31 | 46.25 | 0 | 0.00 |
| 2012-07-31 | 43.30 | 0 | 0.00 |
| 2012-04-30 | 38.30 | 0 | 0.00 |
| 2012-01-31 | 32.50 | 0 | 0.00 |
| 2011-10-31 | 28.80 | 0 | 0.00 |
| 2011-07-31 | 27.14 | 0 | 0.00 |
| 2011-04-30 | 35.59 | 0 | 0.00 |
| 2011-01-31 | 32.75 | 0 | 0.00 |
| 2010-10-31 | 27.51 | 0 | 0.00 |
| 2010-07-31 | 23.82 | 0 | 0.00 |
| 2010-04-30 | 19.53 | 0 | 0.00 |
| 2010-01-31 | 18.74 | 0 | 0.00 |
| 2009-10-31 | 14.46 | 0 | 0.00 |
| 2009-07-31 | 16.61 | 0 | 0.00 |
| 2009-04-30 | 13.24 | 0 | 0.00 |
| 2009-01-31 | 15.39 | 0 | 0.00 |
| 2008-10-31 | 12.74 | 0 | 0.00 |
| 2008-07-31 | 27.62 | 0 | 0.00 |
| 2008-04-30 | 15.80 | 0 | 0.00 |
| 2008-01-31 | 12.00 | 0 | 0.00 |
| 2007-10-31 | 14.50 | 0 | 0.00 |
| 2007-07-31 | 14.00 | 0 | 0.00 |
| 2007-04-30 | 21.86 | 0 | 0.00 |
| 2007-01-31 | 21.07 | 0 | 0.00 |
| 2006-10-31 | 18.03 | 0 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $2.707B | $1.253B |
| LivaNova PLC is a medical technology company which focuses on providing treatment for cardiovascular diseases and neuromodulation. The Company's operating units consists of Cardiac Rhythm Management, Cardiac Surgery and Neuromodulation. LivaNova PLC, formerly known as Cyberonics, Inc., is based in London, United Kingdom. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $212.643B | 25.27 |
| Intuitive Surgical (ISRG) | United States | $196.366B | 76.83 |
| IDEXX Laboratories (IDXX) | United States | $56.993B | 56.60 |
| Edwards Lifesciences (EW) | United States | $47.840B | 32.08 |
| Alcon (ALC) | Switzerland | $36.633B | 24.59 |
| IQVIA Holdings (IQV) | United States | $35.909B | 20.02 |
| Mettler-Toledo (MTD) | United States | $29.655B | 34.41 |
| STERIS (STE) | Ireland | $25.613B | 26.35 |
| DexCom (DXCM) | United States | $22.629B | 31.19 |
| Waters (WAT) | United States | $22.097B | 29.23 |
| Hologic (HOLX) | United States | $16.492B | 17.36 |
| SONOVA HOLDING (SONVY) | Switzerland | $15.914B | 0.00 |
| Penumbra (PEN) | United States | $10.363B | 72.89 |
| Globus Medical (GMED) | United States | $8.334B | 17.33 |
| Masimo (MASI) | United States | $7.726B | 24.76 |
| Sysmex ADR (SSMXY) | Japan | $6.572B | 20.88 |
| Teleflex (TFX) | United States | $4.795B | 7.64 |
| Glaukos (GKOS) | United States | $4.698B | 0.00 |
| TransMedics (TMDX) | United States | $4.271B | 50.60 |
| Veracyte (VCYT) | United States | $3.296B | 37.56 |
| Alphatec Holdings (ATEC) | United States | $2.898B | 0.00 |
| Integer Holdings (ITGR) | United States | $2.335B | 10.96 |
| Artivion (AORT) | United States | $2.241B | 103.26 |
| Nihon Kohden (NHNKY) | Japan | $1.975B | 23.58 |
| PROCEPT BioRobotics (PRCT) | United States | $1.741B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $1.710B | 16.57 |
| AxoGen (AXGN) | United States | $1.106B | 0.00 |
| Beta Bionics (BBNX) | United States | $1.102B | 0.00 |
| IRadimed (IRMD) | United States | $1.076B | 51.28 |
| Pulse Biosciences (PLSE) | United States | $1.066B | 0.00 |
| OPKO Health (OPK) | United States | $1.059B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $0.901B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.874B | 4.73 |
| SiBone (SIBN) | United States | $0.655B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.580B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.535B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.533B | 31.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.519B | 10.35 |
| ClearPoint Neuro (CLPT) | United States | $0.518B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.483B | 0.00 |
| NeuroPace (NPCE) | United States | $0.426B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.415B | 3.26 |
| Mesa Laboratories (MLAB) | United States | $0.412B | 11.41 |
| OrthoPediatrics (KIDS) | United States | $0.411B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.394B | 0.00 |
| RxSight (RXST) | United States | $0.354B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.323B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.305B | 50.82 |
| Spectral Diagnostics (EDTXF) | Canada | $0.295B | 0.00 |
| 908 Devices (MASS) | United States | $0.280B | 0.00 |
| CVRx (CVRX) | United States | $0.263B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.262B | 0.00 |
| Inogen (INGN) | United States | $0.190B | 0.00 |
| Neuronetics (STIM) | United States | $0.173B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.145B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.143B | 0.00 |
| Accuray (ARAY) | United States | $0.138B | 0.00 |
| LENSAR (LNSR) | United States | $0.137B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.136B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.122B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.105B | 0.00 |
| Hyperfine (HYPR) | United States | $0.083B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.082B | 0.00 |
| InspireMD (NSPR) | United States | $0.082B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.076B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.074B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.058B | 0.00 |
| Spectral AI (MDAI) | United States | $0.054B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.039B | 0.00 | |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| DarioHealth (DRIO) | United States | $0.027B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.026B | 0.00 |
| NexGel (NXGL) | United States | $0.019B | 0.00 |
| Envoy Medical (COCH) | United States | $0.019B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.015B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.013B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.013B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.013B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.012B | 0.00 |
| Tenon Medical (TNON) | United States | $0.010B | 0.00 |
| PAVmed (PAVM) | United States | $0.009B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.007B | 0.00 |
| Solana (HSDT) | United States | $0.006B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.005B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 11.68 |